AMPAC Fine Chemicals manufactures active pharmaceutical ingredients and registered intermediates for customers in the pharmaceutical industry. Our state-of-the-art California production facility offers engineering capabilities, including containment for high-potency compounds, energetic and nucleoside chemistries, and chiral separation using commercial-scale simulated moving bed (SMB) technology.

AFC operates in full compliance with the U.S. Food and Drug Administration’s (FDA) current Good Manufacturing Practices (cGMP). We focus on high-growth markets where our technology position, combined with our chemical process, development and engineering expertise, leads to strong customer alliances. Formerly known as Aerojet Fine Chemicals, AFC was acquired by AMPAC in 2005.